Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL600082 | 1.00 | HCAR2 (1.00) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL9874572 | 0.98 | HCAR2 (0.96) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL4212112 | 0.98 | HCAR2 (0.96) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL31591277 | 0.93 | HCAR2 (0.86) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL9117065 | 0.86 | HCAR2 (0.76) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL5598744 | 0.85 | HCAR2 (0.74) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL5598741 | 0.85 | HCAR2 (0.74) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL9580713 | 0.85 | HCAR2 (0.73) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL10332830 | 0.84 | HCAR2 (0.72) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL10332828 | 0.84 | HCAR2 (0.72) | HCAR2ABCG2SMN1; SMN2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122058334-A | Self-sensing artificial muscle, deformation sensing method, preparation method and miniature grabbing device | 江苏大学 | 2026-05-19 | — | — | CN | claimed |
| US-20260133354-A1 | STRUCTURED TRANSFER ARTICLES AND ARTICLES, AND METHODS OF MAKING STRUCTURED ARTICLES | 3M INNOVATIVE PROPERTIES CO (US) | 2026-05-14 | — | — | US | claimed |
| CN-122028974-A | Ribonucleic acid-based microcapsules | 弗门尼舍有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4724261-A1 | METHODS AND SYSTEMS FOR FABRICATING THREE-DIMENSIONAL OBJECTS BY ADDITIVE MANUFACTURING | University Of Tasmania (AU) | 2026-04-15 | — | — | EP | claimed |
| US-20260034034-A1 | COMPOSITE MICROCAPSULES | FIRMENICH & CIE (CH) | 2026-02-05 | — | — | US | claimed |
| EP-4683684-A1 | POST-PROCESSING OF BIOLOGICAL SCAFFOLDS | Lung Biotechnology PBC (US) | 2026-01-28 | — | — | EP | claimed |
| US-20260008933-A1 | UNIFORM UV-CURABLE COATINGS FOR 3D-PRINTED ORTHODONTIC DEVICES AND METHODS FOR PREPARING THE SAME | ALIGN TECHNOLOGY INC (US) | 2026-01-08 | — | — | US | claimed |
| US-20250382499-A1 | WATERBORNE COATING FORMULATION WITH POLYHEDRAL OLIGOMERIC SILSESQUIOXANE, SYNTHETIC METHOD AND APPLICATION THEREOF | NANO & ADVANCED MATERIALS INST LTD (HK) | 2025-12-18 | — | — | US | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4639242-A1 | STRUCTURED TRANSFER ARTICLES AND ARTICLES, AND METHODS OF MAKING STRUCTURED ARTICLES | 3M Innovative Properties Company (US) | 2025-10-29 | — | — | EP | claimed |
| WO-1997047355-A1 | REDUCTION OF SKIN SENSITIZATION IN ELECTROTRANSPORT DRUG DELIVERY | ALZA CORPORATION (US) | 1997-12-18 | — | — | WO | claimed |
| US-5686100-A | Prophylactic and therapeutic treatment of skin sensitization and irritation | E.R. SQUIBB & SONS, INC. (US) | 1997-11-11 | — | — | US | claimed |
| EP-0802782-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF SKIN SENSITIZATION AND IRRITATION | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-10-29 | — | — | EP | claimed |
| EP-0727713-A1 | Photoresist having increased sensitivity and use thereof | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1996-08-21 | — | — | EP | claimed |
| WO-1996015771-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF SKIN SENSITIZATION AND IRRITATION | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-05-30 | — | — | WO | claimed |
| EP-0612525-A1 | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-08-31 | — | — | EP | claimed |
| EP-0440329-A1 | S-substituted carbonyl substituted betathioacrylamide biocides and fungicides | ROHM AND HAAS COMPANY (US) | 1991-08-07 | — | — | EP | claimed |
| EP-0046595-B1 | ACYLATED FURANYL AND THIENYL ACRYLIC ACIDS, PROCESS FOR THEIR PRODUCTION, AND PHARMACEUTICAL COMPOSITIONS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1984-10-24 | — | — | EP | claimed |
| US-3989882-A | Process for preparing an alternating copolymer of a conjugated vinyl compound and an olefinic unsaturated compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-11-02 | — | — | US | claimed |
| US-3945831-A | Photosensitive resins containing a thienylacrylic acid ester or amide group | FUJI PHOTO FILM CO., LTD. (JA) | 1976-03-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034034-A1 | COMPOSITE MICROCAPSULES | S100P, HAMP, PCTP | HCAR2 2846/4885ABCG2 2677/4885SMN1; SMN2 4737/4885 |
| US-20260133354-A1 | STRUCTURED TRANSFER ARTICLES AND ARTICLES, AND METHODS OF MAKING STRUCTURED ARTICLES | ICAM1, CD63, CDH1 | HCAR2 4578/4885ABCG2 4306/4885SMN1; SMN2 918/4885 |
| US-20260008933-A1 | UNIFORM UV-CURABLE COATINGS FOR 3D-PRINTED ORTHODONTIC DEVICES AND METHODS FOR PREPARING THE SAME | MAP1LC3B, MAP1LC3A, MAP1LC3C | HCAR2 2531/4885ABCG2 3722/4885SMN1; SMN2 2207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.